Showing results (271-280 of 293) with videos related to
Sort By:
Pageof 30
Nature Communications|October 26, 2018
A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infectionSlim Fourati, Aarthi Talla, Mehrad Mahmoudian, et al.The New England Journal of Medicine|May 30, 2019
Daratumumab plus Lenalidomide and Dexamethasone for Untreated MyelomaThierry Facon, Shaji Kumar, Torben Plesner, et al.Science Immunology|March 11, 2021
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K Siggins, et al.Nature Communications|December 7, 2025
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infectionHelen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu, et al.Annals of the New York Academy of Sciences|February 1, 2023
Respiratory viruses: New frontiers-a Keystone Symposia reportJennifer Cable, Jie Sun, In Su Cheon, et al.The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Lack of association between HLA and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T Cirulli, Iva Neveux, et al.HGG Advances|April 28, 2024
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T Cirulli, Iva Neveux, et al.Plos One|July 1, 2025
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocolSanjita Brito-Mutunayagam, David O Hamilton, Elena Mitsi, et al.Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.Pageof 30